ABBOTT PARK, Ill., June 13, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough.
![]() ABL 8 months ago | Other | €0.55 Per Share |
![]() ABL 11 months ago | Other | €0.55 Per Share |
![]() ABL 12 Apr 2024 | Other | €0.55 Per Share |
![]() ABL 11 Jan 2024 | Other | €0.55 Per Share |
![]() ABL 12 Oct 2023 | Other | €0.51 Per Share |
16 Jul 2025 (30 Days) Date | | - Cons. EPS | - EPS |
15 Apr 2025 Date | | - Cons. EPS | - EPS |
22 Jan 2025 Date | | - Cons. EPS | - EPS |
16 Oct 2024 Date | | - Cons. EPS | - EPS |
18 Jul 2024 Date | | - Cons. EPS | - EPS |
![]() ABL 8 months ago | Other | €0.55 Per Share |
![]() ABL 11 months ago | Other | €0.55 Per Share |
![]() ABL 12 Apr 2024 | Other | €0.55 Per Share |
![]() ABL 11 Jan 2024 | Other | €0.55 Per Share |
![]() ABL 12 Oct 2023 | Other | €0.51 Per Share |
16 Jul 2025 (30 Days) Date | | - Cons. EPS | - EPS |
15 Apr 2025 Date | | - Cons. EPS | - EPS |
22 Jan 2025 Date | | - Cons. EPS | - EPS |
16 Oct 2024 Date | | - Cons. EPS | - EPS |
18 Jul 2024 Date | | - Cons. EPS | - EPS |
Medical - Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | XDUS Exchange | US0028241000 ISIN |
US Country | 114,000 Employees | 15 Apr 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains: